Ivette Buendía-Roldán

707 total citations
52 papers, 372 citations indexed

About

Ivette Buendía-Roldán is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Immunology. According to data from OpenAlex, Ivette Buendía-Roldán has authored 52 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 15 papers in Infectious Diseases and 12 papers in Immunology. Recurrent topics in Ivette Buendía-Roldán's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (21 papers), COVID-19 Clinical Research Studies (14 papers) and Long-Term Effects of COVID-19 (11 papers). Ivette Buendía-Roldán is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (21 papers), COVID-19 Clinical Research Studies (14 papers) and Long-Term Effects of COVID-19 (11 papers). Ivette Buendía-Roldán collaborates with scholars based in Mexico, Spain and Malaysia. Ivette Buendía-Roldán's co-authors include Gloría Pérez-Rubio, Ramcés Falfán‐Valencia, Leslie Chávez‐Galán, Mayra Mejía, Jorge Rojas‐Serrano, Ingrid Fricke-Galindo, Moisés Selman, Ranferi Ocaña‐Guzmán, Rafael de Jesús Hernández-Zenteno and Lucero A. Ramón‐Luing and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Ivette Buendía-Roldán

43 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ivette Buendía-Roldán Mexico	12	131	106	105	76	66	52	372
Hannelore P. Van Eeckhoutte Belgium	8	127 1.0×	109 1.0×	136 1.3×	81 1.1×	39 0.6×	9	359
Chiara Barbieri Italy	10	126 1.0×	93 0.9×	75 0.7×	57 0.8×	83 1.3×	15	443
Doriana Cellura United Kingdom	8	63 0.5×	200 1.9×	90 0.9×	94 1.2×	72 1.1×	15	392
Wenqing Sun China	12	81 0.6×	221 2.1×	235 2.2×	74 1.0×	54 0.8×	32	566
Cuilian Guo China	9	90 0.7×	61 0.6×	41 0.4×	52 0.7×	24 0.4×	21	337
Yuan Zhan China	9	52 0.4×	61 0.6×	86 0.8×	28 0.4×	127 1.9×	43	343
Christian Ascoli United States	11	42 0.3×	135 1.3×	104 1.0×	48 0.6×	40 0.6×	32	326
Barbara Dierdorp Netherlands	9	72 0.5×	111 1.0×	42 0.4×	167 2.2×	65 1.0×	15	422
Laila Salameh United Arab Emirates	11	45 0.3×	80 0.8×	44 0.4×	47 0.6×	33 0.5×	23	244
Venice Chávez‐Valencia Mexico	8	138 1.1×	28 0.3×	156 1.5×	35 0.5×	37 0.6×	18	407

Countries citing papers authored by Ivette Buendía-Roldán

Since Specialization

Citations

This map shows the geographic impact of Ivette Buendía-Roldán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivette Buendía-Roldán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivette Buendía-Roldán more than expected).

Fields of papers citing papers by Ivette Buendía-Roldán

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivette Buendía-Roldán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivette Buendía-Roldán. The network helps show where Ivette Buendía-Roldán may publish in the future.

Co-authorship network of co-authors of Ivette Buendía-Roldán

This figure shows the co-authorship network connecting the top 25 collaborators of Ivette Buendía-Roldán. A scholar is included among the top collaborators of Ivette Buendía-Roldán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivette Buendía-Roldán. Ivette Buendía-Roldán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ramón‐Luing, Lucero A., Laura E. Martínez-Gómez, Carlos Martínez-Armenta, et al.. (2025). TNF/IFN-γ Co-Signaling Induces Differential Cellular Activation in COVID-19 Patients: Implications for Patient Outcomes. International Journal of Molecular Sciences. 26(3). 1139–1139.

Garrido, M, Mauricio González-García, Fabián Caro, et al.. (2025). Quality of life in idiopathic pulmonary fibrosis in Latin American countries. BMC Pulmonary Medicine. 25(1). 36–36. 1 indexed citations

Bandala, Cindy, Leslie Chávez‐Galán, Ivette Buendía-Roldán, et al.. (2025). Association of Vitamin D Supplementation with Glutathione Peroxidase (GPx) Activity, Interleukine-6 (IL-6) Levels, and Anxiety and Depression Scores in Patients with Post-COVID-19 Condition. International Journal of Molecular Sciences. 26(10). 4582–4582. 3 indexed citations

Buendía-Roldán, Ivette, et al.. (2024). Changes in Sleep Quality in Patients Older than 60 Years, post-COVID Pandemic. Revista de investigaci�n Cl�nica. 76(6). 239–242.

Fricke-Galindo, Ingrid, Gloría Pérez-Rubio, Ivette Buendía-Roldán, et al.. (2024). The Immune Response of OAS1, IRF9, and IFI6 Genes in the Pathogenesis of COVID-19. International Journal of Molecular Sciences. 25(9). 4632–4632. 4 indexed citations

Osuna‐Padilla, Iván Armando, et al.. (2024). Validity of bioelectric impedance analysis for body composition assessment in interstitial lung disease patients. Nutrición Hospitalaria. 41(4). 810–814. 1 indexed citations

Fricke-Galindo, Ingrid, Ivette Buendía-Roldán, Gloría Pérez-Rubio, et al.. (2023). The ACE rs1799752 Variant Is Associated with COVID-19 Severity but Is Independent of Serum ACE Activity in Hospitalized and Recovered Patients. International Journal of Molecular Sciences. 24(8). 7678–7678. 2 indexed citations

Falfán‐Valencia, Ramcés, et al.. (2023). The rs16969968 Tobacco Smoking-Related Single-Nucleotide Variant Is Associated with Clinical Markers in Patients with Severe COVID-19. International Journal of Molecular Sciences. 24(12). 9811–9811. 2 indexed citations

Palacios, Yadira, Lucero A. Ramón‐Luing, Ramcés Falfán‐Valencia, et al.. (2023). COVID-19 patients with high TNF/IFN-γ levels show hallmarks of PANoptosis, an inflammatory cell death. Microbes and Infection. 25(8). 105179–105179. 18 indexed citations

10.

Chávez‐Galán, Leslie, Ramcés Falfán‐Valencia, Ivette Buendía-Roldán, et al.. (2023). Variant rs4986790 of toll-like receptor 4 affects the signaling and induces cell dysfunction in patients with severe COVID-19. International Journal of Infectious Diseases. 138. 102–109. 8 indexed citations

11.

Rojas‐Serrano, Jorge, Gloría Pérez-Rubio, Ivette Buendía-Roldán, et al.. (2023). Molecular Factors in PAD2 (PADI2) and PAD4 (PADI4) Are Associated with Interstitial Lung Disease Susceptibility in Rheumatoid Arthritis Patients. Cells. 12(18). 2235–2235. 13 indexed citations

12.

Chávez‐Galán, Leslie, Martha Torres, Ramcés Falfán‐Valencia, et al.. (2022). Circulating Levels of PD-L1, TIM-3 and MMP-7 Are Promising Biomarkers to Differentiate COVID-19 Patients That Require Invasive Mechanical Ventilation. Biomolecules. 12(3). 445–445. 20 indexed citations

13.

Falfán‐Valencia, Ramcés, Ivette Buendía-Roldán, Leslie Chávez‐Galán, et al.. (2022). COVID-19 Survivor Patients Carrying the Rs35705950 Risk Allele in MUC5B Have Higher Plasma Levels of Mucin 5B. Current Issues in Molecular Biology. 44(8). 3283–3290. 2 indexed citations

14.

Ramos-Martı́nez, Espiridión, Gloría Pérez-Rubio, Mayra Mejía, et al.. (2022). Enhanced Activity of NLRP3 Inflammasome in the Lung of Patients with Anti-Synthetase Syndrome. Cells. 12(1). 60–60. 5 indexed citations

15.

Palacios, Yadira, Lucero A. Ramón‐Luing, Ranferi Ocaña‐Guzmán, et al.. (2021). Severe COVID-19 Patients Show an Increase in Soluble TNFR1 and ADAM17, with a Relationship to Mortality. International Journal of Molecular Sciences. 22(16). 8423–8423. 41 indexed citations

16.

Ocaña‐Guzmán, Ranferi, et al.. (2021). Multidrug-resistant tuberculosis patients expressing the HLA-DRB1*04 allele, and after treatment they show a low frequency of HLA-II+ monocytes and a chronic systemic inflammation. Microbial Pathogenesis. 153. 104793–104793. 9 indexed citations

17.

Fiordelisio, Tatiana, et al.. (2021). Development of a Diagnostic Biosensor Method of Hypersensitivity Pneumonitis towards a Point-of-Care Biosensor. Biosensors. 11(6). 196–196. 1 indexed citations

18.

Machahua, Carlos, Ivette Buendía-Roldán, Ranferi Ocaña‐Guzmán, et al.. (2020). CD4+T cells in ageing-associated interstitial lung abnormalities show evidence of pro-inflammatory phenotypic and functional profile. Thorax. 76(2). 152–160. 11 indexed citations

19.

Ramos-Martı́nez, Espiridión, Ramcés Falfán‐Valencia, Gloría Pérez-Rubio, et al.. (2020). Anti-Aminoacyl Transfer-RNA-Synthetases (Anti-tRNA) Autoantibodies Associated with Interstitial Lung Disease: Pulmonary Disease Progression has a Persistent Elevation of the Th17 Cytokine Profile. Journal of Clinical Medicine. 9(5). 1356–1356. 21 indexed citations

20.

Rodrı́guez-Reyna, Tatiana Sofia, et al.. (2020). The Transcription Factor SCX is a Potential Serum Biomarker of Fibrotic Diseases. International Journal of Molecular Sciences. 21(14). 5012–5012. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact